ABBV-383
Product Specifications
Target
Integrin
Related Pathways
Cytoskeletal Signaling
Bioactivity
ABBV-383 (ABBV-383), a BCMA x CD3 bispecific T-cell engager (BiTE), targets and inhibits the B-cell maturation antigen (BCMA) while concurrently activating the T-cell surface glycoprotein CD3 complex. This compound is utilized in research focused on multiple myeloma, immunoglobulin light chain amyloidosis, and cardiovascular diseases.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog